Antibody-related drugs can be used to treat major diseases such as malignant tumors, immune diseases, infectious or allergic diseases, blood or extracellular fluid diseas…
-----What matters in IP protection in China After 24 years of implementation of the Anti-Unfair Competition Law (hereinafter referred to as "Existing law"), the first am…
How much disclosure is appropriate for the background section of a patent application? This question is difficult to answer, especially when it applies to a multinat…
Chen Xiaofan of Liu Shen & Associates explains the significance of China’s change of heart on business method innovations. 11th November is an importa…
Sufficient disclosure of an invention is required under the Patent Law of China. According to Article 26, Clause 3 of the law, “the description shall set forth the inventio…
Under the provision of Article 33 of the Patent Law of China, an applicant may amend his or its application for a patent, but the amendment to the application fo…
